Marker Therapeutics, Inc. — Director's Dealing 2004

Feb 17, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENEMAX CORP (GMXX)
CIK: 0001094038
Period of Report: 2003-12-16

Reporting Person: HANDFORD RONALD L (Director, President/CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-12-16	Stock Options	$0.50	A	200000	Acquired	2011-12-16	Common Stock (200000)	Direct

Footnotes

F1: Granted in accordance with the terms and provisions of the Stock Option Plan dated December 16, 2003, in consideration of services and duties performed.